They raise the funds and do what is needed to get the drug approved. We get upside with no risk. They are going pre-clinical in the second half of 2025, so benefit to us is still sometime out. But, with the market opportunity in the US alone of $190 million, it's meaningful.
They raise the funds and do what is needed to get the drug...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $128.9M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.3¢ | $188.8K | 13.50M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 20724621 | 1.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.4¢ | 1182673 | 6 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| ATH (ASX) Chart |